Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,654 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mortality after surgery in Europe: a 7 day cohort study.
Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, Vallet B, Vincent JL, Hoeft A, Rhodes A; European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology. Pearse RM, et al. Lancet. 2012 Sep 22;380(9847):1059-65. doi: 10.1016/S0140-6736(12)61148-9. Lancet. 2012. PMID: 22998715 Free PMC article.
Ventilation and outcomes following robotic-assisted abdominal surgery: an international, multicentre observational study.
Assessment of Ventilation during general AnesThesia for Robotic surgery (AVATaR) Study Investigators; PROtective VEntilation (PROVE) Network; Writing Committee Members; Steering Committee Members; AVATaR Investigators. Assessment of Ventilation during general AnesThesia for Robotic surgery (AVATaR) Study Investigators, et al. Br J Anaesth. 2021 Feb;126(2):533-543. doi: 10.1016/j.bja.2020.08.058. Epub 2020 Oct 31. Br J Anaesth. 2021. PMID: 33131757 Free article.
A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal Osteoporosis.
Paul T, Garg B, Kapoor N, Patil V, Kachnerkar N, Shembalkar J, Purohit S, Maheshwari S, Maheshwari S, Yadav A, Cherian JJ, Agrawal A, Basu K, Tripathy SK, Pongde AB, Goni V, Markade P, Makane A, Tiwaskar M, Cherian KE, Rane Y, Shahavi V, Poojary V, Somani R, Gondane A, Aiwale A, Pawar D, Pawar R, Sharma A. Paul T, et al. Among authors: patil v. J Assoc Physicians India. 2025 Jan;73(1):e8-e13. doi: 10.59556/japi.73.0772. J Assoc Physicians India. 2025. PMID: 39893524 Clinical Trial.
Bilateral macronodular adrenocortical disease (BMAD): a single centre experience.
Ban A, Barnabas R, Karlekar M, Lila AR, Yami Channaiah C, Memon SS, Patil VA, Sarathi V, Fernandes G, Thakkar H, Rege S, Shah NS, Bandgar T. Ban A, et al. Among authors: patil va. Endocr Connect. 2025 Jan 1:EC-24-0664. doi: 10.1530/EC-24-0664. Online ahead of print. Endocr Connect. 2025. PMID: 39887684 Free article.
Assessing neoadjuvant chemotherapy's impact on complications following radical cystectomy.
Nuthalapati M, Menon AR, Patil VD, Sukumaran SV, Yensani PR, Agrawal S, Haridas NK, Nair H, Ganesuni SC, Suresh N, Rajamma BM, Pooleri GK. Nuthalapati M, et al. Among authors: patil vd. Indian J Urol. 2025 Jan-Mar;41(1):28-34. doi: 10.4103/iju.iju_217_24. Epub 2025 Jan 1. Indian J Urol. 2025. PMID: 39886627 Free PMC article.
Under-representation of older Indian persons with cancer in clinical trials.
Noronha V, Patil V, Menon N, Kolkur M, Peelay Z, Shah M, Mathrudev V, Shah S, Nawale K, Nair NS, Ramaswamy A, Ostwal V, Ghosh-Laskar S, Agarwal JP, Chaturvedi P, Chopra S, Murthy V, Myatra SN, Divatia J, Gota V, Gupta S, Chaudhari V, Jiwnani S, Shrikhande SV, Vaish R, Chaukar D, Thiagarajan S, Nair S, D'Cruz A, Oak A, Hawaladar R, Roy Chowdhury O, Banavali S, Badwe R, Prabhash K. Noronha V, et al. Among authors: patil v. BMJ Oncol. 2024 Aug 12;3(1):e000445. doi: 10.1136/bmjonc-2024-000445. eCollection 2024. BMJ Oncol. 2024. PMID: 39886158 Free PMC article.
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
Guglielmetti L, Khan U, Velásquez GE, Gouillou M, Abubakirov A, Baudin E, Berikova E, Berry C, Bonnet M, Cellamare M, Chavan V, Cox V, Dakenova Z, de Jong BC, Ferlazzo G, Karabayev A, Kirakosyan O, Kiria N, Kunda M, Lachenal N, Lecca L, McIlleron H, Motta I, Toscano SM, Mushtaque H, Nahid P, Oyewusi L, Panda S, Patil S, Phillips PPJ, Ruiz J, Salahuddin N, Garavito ES, Seung KJ, Ticona E, Trippa L, Vasquez DEV, Wasserman S, Rich ML, Varaine F, Mitnick CD; endTB Clinical Trial Team. Guglielmetti L, et al. N Engl J Med. 2025 Jan 30;392(5):468-482. doi: 10.1056/NEJMoa2400327. N Engl J Med. 2025. PMID: 39879593 Free PMC article. Clinical Trial.
1,654 results